Allegro Ophthalmics
PrivateLast Round
VC Round
Jul 24, 2017
Total Funding Raised
$22.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Allegro Ophthalmics operates in Healthcare & Life Sciences and is based in San Juan Capistrano, California. Its latest recorded funding round was a VC Round in July 2017.
Allegro Ophthalmics is a biopharmaceutical company that develops novel therapies for ocular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allegro Ophthalmics Comparables
Compare Allegro Ophthalmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morningside | 84% | |
| Drusolv Therapeutics | 78% | |
| AsclepiX Therapeutics | 78% |
For institutional investors. Book with your work email.
Allegro Ophthalmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 24, 2017 | ||||
| Grant | Feb 3, 2015 | ||||
| Series B | Jan 13, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Allegro Ophthalmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helmsley Charitable Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 30% MoM.
- Jan 8, 2026
Monthly visitors grew 340% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
Allegro Ophthalmics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Allegro Ophthalmics's valuation, stock price, and market status.
Is Allegro Ophthalmics a public or private company?
Allegro Ophthalmics is a private company.
What is the current stock price of Allegro Ophthalmics?
Allegro Ophthalmics is a private company, so its shares have no public market price. Caplight tracks Allegro Ophthalmics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Allegro Ophthalmics worth (valuation)?
Valuation information for Allegro Ophthalmics is not publicly available.
Can I buy Allegro Ophthalmics stock?
Allegro Ophthalmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Allegro Ophthalmics's last funding round?
Allegro Ophthalmics's most recent funding round was VC Round on July 24, 2017.
Who are the main investors in Allegro Ophthalmics?
Key investors in Allegro Ophthalmics include Helmsley Charitable Trust.
Will Allegro Ophthalmics IPO soon?
No public IPO plans have been announced for Allegro Ophthalmics.
How can I track Allegro Ophthalmics secondary market activity?
Caplight tracks bids, offers, and trades in Allegro Ophthalmics's shares on secondary markets.